“…This relatively long equilibration time cannot be entirely explained by the slow adsorption of higher molecular weight chains. Compared with the previous experimental and theoretical studies on polymer adsorption (Berglund et al 2003a(Berglund et al , 2003bEvertsson and Nilsson, 1997), our drug surfaces that are continually dissolving and precipitating are "non-ideal." Furthermore, during nanocomminution, the situation is complex since the fracturing process continually generates fresh surfaces and the aggregation process continually destroys these surfaces.…”